Abstract
Exploring the fundamental mechanisms behind the low tumour uptake of labelled monoclonal antibodies (MoAbs) during in vivo immunotargeting, experiments were performed to estimate the in vivo value of the association constant (Ka) in an experimental targeting reaction. An artificial tumour model was utilised, based on diffusion chambers (DC) filled with antigen-coated polymer particles, implanted i.p. in normal, immunocompetent mice (NMRI/BOM). The MoAb H7 with specificity for placental alkaline phosphatase (PLALP) was chosen for this experiment. Each mouse carried two DC, one target DC filled with PLALP-coated particles, and a second control DC with the same amount of uncoated particles. The DC contained escalating doses of particles, ranging from 0.1 mg to 16 mg per DC, with groups of 6-12 animals per dose level. The next day after the implantation, a constant dose of 125I-labelled Fab fragments of H7 was injected i.v. in each mouse. The association constant Ka as measured from the binding data obtained in vivo was not significantly different from the value measured in vitro when the same target DC were incubated with the 125I-Fab in test tubes. This indicates that in vivo impairment of the antibody avidity is not the reason why a relatively low tumour uptake is generally experienced in immunotargeting studies.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Benestad H. B., Reikvam A. Diffusion chamber culturing of haematopoietic cells: methodological investigations and improvement of the technique. Exp Hematol. 1975 Aug;3(4):249–260. [PubMed] [Google Scholar]
- Epenetos A. A., Kosmas C. Monoclonal antibodies for imaging and therapy. Br J Cancer. 1989 Feb;59(2):152–155. doi: 10.1038/bjc.1989.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fjeld J. G., Benestad H. B., Stigbrand T., Nustad K. In vivo evaluation of radiolabelled antibodies with antigen-coated polymer particles in diffusion chambers. J Immunol Methods. 1988 Apr 22;109(1):1–7. doi: 10.1016/0022-1759(88)90435-8. [DOI] [PubMed] [Google Scholar]
- Fjeld J. G., Bruland O. S., Benestad H. B., Schjerven L., Stigbrand T., Nustad K. Radioimmunotargeting of human tumour cells in immunocompetent animals. Br J Cancer. 1990 Oct;62(4):573–578. doi: 10.1038/bjc.1990.332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
- Jain R. K. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst. 1989 Apr 19;81(8):570–576. doi: 10.1093/jnci/81.8.570. [DOI] [PubMed] [Google Scholar]
- Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
- Matzku S., Kirchgessner H., Dippold W. G., Brüggen J. Immunoreactivity of monoclonal anti-melanoma antibodies in relation to the amount of radioactive iodine substituted to the antibody molecule. Eur J Nucl Med. 1985;11(6-7):260–264. doi: 10.1007/BF00279081. [DOI] [PubMed] [Google Scholar]
- Millán J. L., Stigbrand T. Antigenic determinants of human placental and testicular placental-like alkaline phosphatases as mapped by monoclonal antibodies. Eur J Biochem. 1983 Oct 17;136(1):1–7. doi: 10.1111/j.1432-1033.1983.tb07697.x. [DOI] [PubMed] [Google Scholar]
- Nustad K., Johansen L., Ugelstad J., Ellingsen T., Berge A. Hydrophilic monodisperse particles as solid-phase material in immunoassays: comparison of shell-and-core particles with compact particles. Eur Surg Res. 1984;16 (Suppl 2):80–87. doi: 10.1159/000128626. [DOI] [PubMed] [Google Scholar]